Literature DB >> 26527549

X-linked Agammaglobulinemia With Normal Immunoglobulin and Near-Normal Vaccine Seroconversion.

Kahn Preece1, Graeme Lear2.   

Abstract

We present a 22-month-old boy with X-linked agammaglobulinemia masked by normal immunoglobulin levels and vaccine seroconversion. Diagnosis was made after strong clinical suspicion of immune deficiency led to identification of markedly reduced B-cell numbers and confirmation with identification of a novel Bruton tyrosine kinase gene mutation. He was commenced on replacement immunoglobulin therapy with excellent clinical improvement. This case highlights the variability of phenotypic presentation and apparent disunity between routine immunologic investigations and severe disease in X-linked agammaglobulinemia, necessitating clinical acumen to make the diagnosis.
Copyright © 2015 by the American Academy of Pediatrics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26527549     DOI: 10.1542/peds.2014-3907

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

1.  X-linked agammaglobulinemia: ınvestigation of clinical and laboratory findings, novel gene mutations and prevention of ınfective complications in long-term follow-up.

Authors:  İlke Yıldırım; Ezgi Topyıldız; Raziye Burcu Güven Bilgin; Ayça Aykut; Asude Durmaz; Neslihan Edeer Karaca; Guzide Aksu; Necil Kutukculer
Journal:  Am J Clin Exp Immunol       Date:  2021-02-15

2.  B cell repertoire in patients with a novel BTK mutation: expanding the spectrum of atypical X-linked agammaglobulinemia.

Authors:  Yu Nee Lee; Amit Nahum; Ori Toker; Arnon Broides; Atar Lev; Amos J Simon; Orli Megged; Oded Shamriz; Yuval Tal; Raz Somech
Journal:  Immunol Res       Date:  2022-01-10       Impact factor: 2.829

3.  Disseminated Pseudomonas aeruginosa sepsis as presenting diagnosis of X-linked agammaglobulinaemia in a previously well 16-month-old child.

Authors:  Naveen Kumar Bhardwaj; Daisy Khera; Neeraj Gupta; Kuldeep Singh
Journal:  BMJ Case Rep       Date:  2017-08-29

4.  Mucosal IgA Prevents Commensal Candida albicans Dysbiosis in the Oral Cavity.

Authors:  Nicolas Millet; Norma V Solis; Marc Swidergall
Journal:  Front Immunol       Date:  2020-10-22       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.